Clinical trials
Tuberculosis clinical trials
Below are recruiting tuberculosis clinical trials, each written for real people, not researchers. We’re tracking 150 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06946784Recruiting
Long-term lung health after tuberculosis in Korea
This study looks at how tuberculosis affects your lungs and daily life over the long term. It helps researchers understand the lasting impacts so they can improve care for people who have had TB.
SeoulAges 19 years+ - NCT07170800RecruitingPhase 2
Study of JDB0131 for drug-resistant TB
This trial tests a new tablet called JDB0131 for people with tuberculosis (TB) that is resistant to the antibiotic rifampicin. The goal is to see if it can effectively treat this hard-to-treat form of TB.
Wuhan, HubeiAges 14 years+ - NCT06751706Enrolling by invitation
Testing blood for TB in patients and their household contacts
This study looks for TB bacteria in the blood of people with active tuberculosis and their close contacts at home. It aims to find better ways to detect TB early and prevent its spread.
KampalaAges 18 years+ - NCT06728930Enrolling by invitation
New test for diagnosing latent and active TB
This study tests a new type of lab test to find TB bacteria more accurately. It is for people who are being checked for latent (hidden) TB infection, or who have just been diagnosed with active TB. The goal is to see if the new test can help doctors diagnose TB better and faster.
LondonAges 18 years+ - NCT07484490Recruiting
Breathing exercises with and without balloon blowing for TB in children
This trial tests whether adding a fun balloon-blowing exercise to a standard breathing technique helps children with tuberculosis clear mucus from their lungs more easily. It compares two groups: one using the breathing technique alone, and one using it together with balloon blowing.
LahoreAges 8–14 - NCT07525427RecruitingPhase 2
New Tuberculosis Drug Study for Drug-Sensitive TB
This study tests a new tuberculosis drug called TBD09 combined with other TB medicines in people with newly diagnosed, drug-sensitive TB. The goal is to see if this combination works well and is safe.
Durban, BluffAges 18–65 - NCT07097961Recruiting
Rehab program for kids with lung damage after TB
This study tests a rehab program for children aged 6-17 who have lung damage from a past tuberculosis (TB) infection. The program uses mild-to-moderate physical activity to help improve their breathing and daily life.
KampalaAges 6–17 - NCT07575061Recruiting
Long-term study of survival factors in intestinal tuberculosis
This 15-year study follows patients with intestinal tuberculosis (a bacterial infection of the digestive tract) to understand what factors affect how long patients survive and live with this condition. The research may help doctors better predict outcomes and improve care for future patients.
Beijing, Beijing MunicipalityAges 18–100 - NCT07708779RecruitingPhase 1
Inhaled isoniazid for tuberculosis treatment
This trial tests inhaled isoniazid (medicine) given through a nebulizer to see how well it works and how safe it is. It's for people being treated for tuberculosis.
GroningenAges 18 years+ - NCT03691883Recruiting
Using an algorithm to stage tuberculosis
This trial helps doctors organize and “stage” tuberculosis (TB) using a structured approach. It may improve how care decisions are made by using confirmed TB information and donated samples/data.
Badalona, BarcelonaAges Any age - NCT04052022Recruiting
Study of TB flare-ups in people without HIV
This study looks at why some people with tuberculosis (TB) get worse or develop new inflammation after they initially start improving on treatment—called a “paradoxical reaction.” It collects blood and tissue samples to better understand these flare-ups and guide future care.
Bethesda, MarylandAges 18–99 - NCT04147286RecruitingPhase 2/Phase 3
Atorvastatin to lower lingering inflammation after TB treatment
This trial studies whether atorvastatin (a cholesterol medicine) can reduce ongoing inflammation after you finish standard tuberculosis (TB) treatment. If it works, it may improve how your body recovers after TB, especially by lowering inflammation-related signals.
Observatory, WCAges 18–65 - NCT04700579Recruiting
Study lung changes before and after treatment for active TB
This study looks at changes in the lungs and immune system before TB treatment and again after treatment. By sampling lung fluid and comparing it over time, researchers hope to learn signatures that reflect how TB responds to care.
Cape Town, Western CapeAges 18–60 - NCT05022238Recruiting
Screening for drug-resistant TB hotspots in Namibia
This study tries to find more cases of drug-resistant tuberculosis (TB that doesn’t respond to usual medicines) by checking people in specific regions, households, hospitals, and high-risk “hotspots.” It may help detect TB earlier and link more people to treatment.
WindhoekAges Any age - NCT05022862Recruiting
Check how incentives and vDOT help latent TB treatment
This trial studies whether reminder-based “vDOT” and small economic incentives can help people complete treatment for latent (sleeping) tuberculosis. If you have latent TB and are starting a standard medicine plan, it may help you stay on track and finish safely.
Baltimore, MarylandAges 18 years+ - NCT05401071RecruitingPhase 2/Phase 3
Test shorter rifapentine-based treatment for drug-sensitive TB
This trial studies whether a rifapentine-based TB regimen can work just as well while shortening treatment time. It’s for people with rifampicin-sensitive, smear-positive lung tuberculosis.
Guiyang, GuizhouAges 18–60 - NCT05443178RecruitingPhase 1
Testing chloroquine added to tuberculosis treatment for safety
This Phase 1 study tests how safe and tolerable chloroquine is when given alongside standard tuberculosis medicine. It mainly involves healthy volunteers and helps researchers understand side effects and safe dosing.
ZurichAges 18–50 - NCT05473520RecruitingPhase 3
Doxycycline add-on therapy for lung improvement in tuberculosis
This Phase 3 trial tests whether adding doxycycline to standard TB medicine can improve lung function and reduce lung tissue damage. It aims to see if patients recover better by targeting the lung response to TB.
Kota Kinabalu, SabahAges 21 years+ - NCT05539014Recruiting
Study of newly diagnosed tuberculosis patients at Avicenne Hospital
This study follows people who are newly treated for tuberculosis, including lung and non-lung (extra-lung) cases. It may help doctors better understand tuberculosis and how patients respond after treatment starts.
BobignyAges 18–80 - NCT05553236Recruiting
Using gene testing to guide treatment for drug-resistant tuberculosis
This study uses next-generation gene testing to help manage active drug-resistant tuberculosis. It may help doctors choose the most appropriate treatment by better identifying the TB’s drug resistance.
Cape TownAges Any age - NCT05571735Recruiting
COVID vaccine immune response study in people with tuberculosis
This study measures how strongly your immune system responds to COVID-19 vaccines. It includes people with newly diagnosed tuberculosis and a healthier comparison group, aiming to understand vaccine immune effects and safety.
Mae Ramat, Changwat TakAges 18 years+ - NCT05655702Recruiting
Drug use and infections study for tuberculosis control in Vietnam
This study looks at how injecting drug use is linked with infections, including tuberculosis, and aims to improve TB control. You may be asked to share information and provide tests related to recent drug use and injection sites.
HaiphongAges 18 years+ - NCT05807399RecruitingPhase 2
Step2c trial for new, drug-susceptible lung TB
This Phase 2 study tests treatment for people with newly diagnosed, drug-susceptible pulmonary (lung) tuberculosis (TB). It aims to see whether the study treatment works well and is safe for curing TB.
LambarénéAges 18–65 - NCT05941052Recruiting
Testing new at-home TB checks in the clinic
This study tests new tools that can check for tuberculosis (TB) more quickly at or near where care happens. It includes people with cough or TB risk factors, and also the health workers who perform TB testing, to see how well the tests work and how easy they are to use.
AbujaAges 12 years+
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for tuberculosis?
- Yes. Clin2 currently lists 150 recruiting tuberculosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a tuberculosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a tuberculosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.